Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-21-019051
Filing Date
2021-09-22
Accepted
2021-09-22 16:53:34
Documents
1
Period of Report
2021-09-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_163234399960979.html 4  
1 FORM 4 wf-form4_163234399960979.xml 4 13068
  Complete submission text file 0001628280-21-019051.txt   14423
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Issuer) CIK: 0001600620 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address #1203-4464 MARKHAM STREET VICTORIA A1 BC V8Z7X8
Business Address
Huizinga Robert Bindert (Reporting) CIK: 0001837648 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36421 | Film No.: 211270130